No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

per de Mey, Christian, Nassr, Nassr, Lahu, Gezim
Publicat 2011

Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Di...

per Facius, Axel, Marostica, Eleonora, Gardiner, Philip, Watz, Henrik, Lahu, Gezim
Publicat a Clin Pharmacokinet (2018)

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD

per Holz, Olaf, Roepcke, Stefan, Watz, Henrik, Tegtbur, Uwe, Lahu, Gezim, Hohlfeld, Jens M
Publicat a Int J Chron Obstruct Pulmon Dis (2015)

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations

per Plock, Nele, Facius, Axel, Lahu, Gezim, Wood, Nolan, Frigo, Timothy, Deveney, Aaron, Aceves, Pau
Publicat a Clin Pharmacokinet (2014)

Pharmacokinetics and pharmacodynamics of the cytolytic anti‐CD38 human monoclonal antibody TAK‐079 in monkey – model assisted preparation for the first in human trial

per Roepcke, Stefan, Plock, Nele, Yuan, Josh, Fedyk, Eric R., Lahu, Gezim, Zhao, Lin, Smithson, Glennda
Publicat a Pharmacol Res Perspect (2018)

What Can Be Learned From Crowdsourced Population Asparagus Urinary Odor Kinetics?

per Facius, Axel, Atkinson, Linda A., Hanna, Kelly, Coombes, Mai Chi, Lahu, Gezim, Wagner, John A.
Publicat a CPT Pharmacometrics Syst Pharmacol (2019)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

per Rodriguez‐Romero, Violeta, Bergstrom, Richard F., Decker, Brian S., Lahu, Gezim, Vakilynejad, Majid, Bies, Robert R.
Publicat a Clin Transl Sci (2019)

Model‐Based Approach to Predict Adherence to Protocol During Antiobesity Trials

per Sharma, Vishnu D., Combes, François P., Vakilynejad, Majid, Lahu, Gezim, Lesko, Lawrence J., Trame, Mirjam N.
Publicat a J Clin Pharmacol (2017)

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects

per Nassr, Nassr, Huennemeyer, Andreas, Herzog, Rolf, von Richter, Oliver, Hermann, Robert, Koch, Manuela, Duffy, Kevin, Zech, Karl, Lahu, Gezim
Publicat 2009

Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum

per Röpcke, Stefan, Holz, Olaf, Lauer, Gereon, Müller, Meike, Rittinghausen, Susanne, Ernst, Peter, Lahu, Gezim, Elmlinger, Martin, Krug, Norbert, Hohlfeld, Jens M.
Publicat 2012

Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti‐CD38 cytolytic antibody TAK‐079 in healthy subjects

per Fedyk, Eric R., Zhao, Lin, Koch, Annelize, Smithson, Glennda, Estevam, Jose, Chen, Grace, Lahu, Gezim, Roepcke, Stefan, Lin, Jianchang, Mclean, Lachy
Publicat a Br J Clin Pharmacol (2020)

Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects

per Nassr, Nassr, Lahu, Gezim, von Richter, Oliver, Reutter, Felix, Knoerzer, Dietrich, Zech, Karl, Erb, Katharina A, Schug, Barbara, Blume, Henning, Hermann, Robert
Publicat 2007